DCDC2 p.Ser4=
c.12C>T · VCV3761554
Computational evidence
| Protein change | ||
| AlphaMissense | 0.1046 | likely benign |
|---|---|---|
| REVEL | 0.036 | moderately benign-leaning |
| SaProt | LLR -8.24 | tolerated |
| ⇒ AlphaMissense, REVEL and SaProt all call this tolerated. | ||
| Splicing | ||
| SpliceAI | — | not looked up on this page · why |
| Constraint at this position | ||
| Conservation | phyloP -0.067 | GERP -0.077 |
| Overall | ||
| CADD | 12.99 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| East Asiangrpmax | 0.00446% | 22,430 |
| European (non-Finnish) | 0.000509% | 196,560 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- DCDC2
- Protein
- p.Ser4=
- Coding
- c.12C>T
- Type
- single nucleotide variant
- Location
- chr6:24357739 (GRCh38)
Disease context
isolated neonatal sclerosing cholangitis — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: autosomal recessive nonsyndromic hearing loss 66
For Isolated neonatal sclerosing cholangitis (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- Neonatal
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/dcdc2-p-ser4 (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown